[So. Africa]: GlaxoSmithKline...announced last week it had issued a voluntary licence to Feza Pharmaceuticals [joint venture Creative Outsourcing Solutions International (COSi) & African Healthcare Solutions (AHS)], to make generic copies of its patented [Aids] drugs lamivudine, zidovudine and a combination of the two. [also refers to Boehringer Ingelheim, Thembalam i Pharmaceuticals (joint venture Adcock Ingram & Ranbaxy Laboratories)]